Medical News

RSS

AUA experts urge to focus on urologic health conditions in upcoming year

This new year, make a resolution to improve your health and talk to your doctor about urologic conditions. Although urologic problems may seem embarrassing to talk about, these conditions are more common than you think and a delay in seeking medical attention could cause you unnecessary stress, prolong the problem and even increase your risk for a more serious condition.

30 Dec 2009

UB neurobiologist studies the impact of acute and chronic caffeine consumption in young people

Caffeine is a stimulant drug, although legal, and adults use it widely to perk themselves up: Being "addicted" to caffeine is considered perfectly normal.

30 Dec 2009

Dentists, chiropractors and physical therapists to see rise in revenues from mid-2010: IBISWorld

With the economy showing signs of recovery, industry research firm IBISWorld analyzed more than 700 industries to identify the winning sectors in the coming year.

30 Dec 2009

Compugen raises $20M through sale of 4.1M ordinary shares

Compugen Ltd. today announced it has raised gross proceeds of $20 million, completing in full its previously announced Controlled Equity Offering facility. Under this facility, a total of approximately 4.1 million ordinary shares were sold at a weighted average price of approximately $4.91 per share. These shares were sold in the open market at prevailing prices during the period November 13, 2009 to December 29, 2009.

30 Dec 2009

AngioDynamics introduces new family of micro-introducer kits with stiffened introducer option

AngioDynamics today announced the launch of a new family of micro-introducer kits, featuring a stiffened introducer option.

30 Dec 2009

Burr Leonard launches The Bar Method program at Rancho La Puerta

Burr Leonard, Founder of The Bar Method and author of the popular Bar Method Exercise Blog, announced the launch of The Bar Method program at Rancho La Puerta, the famous destination spa located near San Diego.

30 Dec 2009

J&JPRD receives FDA Complete Response Letter for ceftobiprole

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for ceftobiprole. The New Drug Application (NDA) was originally submitted to the FDA in May 2007 for the treatment of complicated skin and skin structure infections (cSSSI), including diabetic foot infections.

30 Dec 2009

NCD's monthly bulletin for December, 2009

National Council on Disability's monthly bulletin for December 2009.

30 Dec 2009

Nutrisystem to take non cash charge of $5 million as impairment charge

Nutrisystem, Inc., a leading provider of weight management products and services, today announced that it expects to take a non cash charge of up to $5 million before taxes to reflect an impairment charge on the value of the goodwill and identifiable intangibles related to its Nu-Kitchen fresh food delivery business that currently services the New York City area, which the company acquired in July 2008.

30 Dec 2009

Relieve stress: Exercise, meditate, delegate tasks, diet and be happy

It's impossible to know, unless you're Urban Meyer or one of his doctors, what exactly caused the two-time college football championship winner to see-saw decisions about his prestigious professional career and his family life.

30 Dec 2009

State officials release updated fish consumption advisories

State officials today released updated fish consumption advisories that include two new fish species and a water body that had not previously been on the list, but also eases or lifts advisories on fish from seven water bodies.

30 Dec 2009

CLSI and APHL announce 2010 educational teleconferences

Clinical and Laboratory Standards Institute (CLSI) and Association of Public Health Laboratories (APHL) recently announced the January–June 2010 schedule of educational teleconferences for clinical, public health, and veterinary laboratories.

30 Dec 2009

Meda expands collaboration with Etypharm for Axorid

Meda expands the collaboration with the French development company Etypharm for the patented product Axorid. New territories, such as East Europe with Russia and Turkey, are now included in the collaboration. Previously, Meda held commercialization rights in Central and West Europe.

30 Dec 2009

Service dogs for people with disabilities

When disability or illness makes it difficult to open a door, pick up keys or call for help, a service dog might ease these frustrations of daily living.

30 Dec 2009

Overview of grief

A death of a loved one, a job loss, the end of a marriage, an illness or disability. Everyone faces losses and grief, but the toll that grief can take on the mind and body can catch many people by surprise.

30 Dec 2009

NYBC calls for blood donation in recognition of National Blood Donor Month

New York Blood Center (NYBC) and its divisions in Manhattan, Long Island, Hudson Valley, Brooklyn/Staten Island, and New Jersey call upon the community to please donate blood, in recognition of National Blood Donor Month, and to help save lives.

30 Dec 2009

PIMS returns more than $104,000 in experience credit payments

Premier Insurance Management Services Inc. (PIMS) has returned more than $104,000 in experience credit payments to 27 Premier healthcare alliance member hospitals and healthcare systems that participate in the PIMS Fidelity and Fiduciary Liability sponsored insurance program.

30 Dec 2009

RNAO calls for entries to its 12th annual Awards for Excellence in Health-Care

News stories about H1N1 have dominated the media during the past few months, but throughout 2009 journalists reported on a variety of other health and health-care issues that affected the lives of nurses, patients and all Ontarians. As the year draws to a close, the Registered Nurses' Association of Ontario (RNAO) is asking reporters, editors and producers to look back over their work and enter the 12th annual Awards for Excellence in Health-Care Reporting.

30 Dec 2009

Santarus submits rifamycin SV MMX IND to the FDA

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) requesting approval to begin a Phase III clinical program evaluating rifamycin SV MMX® in patients with travelers’ diarrhea.

30 Dec 2009